Stock Events

Stock Events

Neoleukin Therapeutics (NLTX) Q3 2023 Earnings

14NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.41

-0.29

-0.16

-0.04

Details

Expected EPS

N/A

Actual EPS

-0.41

Surprise EPS

-0.41

Surprise Percent

+∞%

Description

Neoleukin Therapeutics (NLTX) has reported earnings of -0.41 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.